TIAA CREF INVESTMENT MANAGEMENT LLC - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 88 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q4 2016. The put-call ratio across all filers is 1.27 and the average weighting 0.0%.

Quarter-by-quarter ownership
TIAA CREF INVESTMENT MANAGEMENT LLC ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2019$3,107,000
+48.9%
169,316
+0.8%
0.00%0.0%
Q4 2018$2,087,000
-69.2%
168,003
-52.5%
0.00%0.0%
Q3 2018$6,774,000
+160.8%
353,326
+85.0%
0.00%0.0%
Q2 2018$2,597,000
+699.1%
190,952
+8.6%
0.00%
Q1 2017$325,000
+9.8%
175,805
-7.8%
0.00%
Q4 2016$296,000
-78.3%
190,726
+2.9%
0.00%
-100.0%
Q3 2016$1,362,000
+35.7%
185,299
-1.8%
0.00%0.0%
Q2 2016$1,004,000188,7220.00%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q4 2016
NameSharesValueWeighting ↓
Western Financial Corp/CA 820,320$33,272,17921.56%
Aquilo Capital Management, LLC 1,103,515$44,758,56816.81%
M28 Capital Management LP 143,900$5,836,5845.56%
WEALTH EFFECTS LLC 155,620$6,311,9513.60%
Evolutionary Tree Capital Management, LLC 92,095$3,735,3733.59%
Privium Fund Management B.V. 221,015$8,867,1223.36%
JOHNSON & JOHNSON 247,598$10,0432.92%
COMMODORE CAPITAL LP 462,111$18,7432.82%
Avidity Partners Management LP 1,375,000$55,770,0001.21%
Capital Impact Advisors, LLC 26,853$1,089,1581.06%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders